Series D · Healthtech
Cagent Vascular: Series D
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease
Funding history
Series D · This round$41M
Loading rounds…
Develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease